PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 162 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $107,000 | -38.2% | 12,176 | -24.1% | 0.00% | – |
| Q3 2019 | $173,000 | +193.2% | 16,046 | +453.3% | 0.00% | – |
| Q4 2018 | $59,000 | -98.4% | 2,900 | -96.5% | 0.00% | -100.0% |
| Q3 2018 | $3,778,000 | -41.8% | 82,378 | -24.9% | 0.01% | -44.4% |
| Q2 2018 | $6,492,000 | +1402.8% | 109,751 | +2412.6% | 0.01% | +800.0% |
| Q4 2017 | $432,000 | -79.6% | 4,368 | -86.2% | 0.00% | -75.0% |
| Q3 2016 | $2,115,000 | – | 31,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |